NCT06685055View on ClinicalTrials.gov

Markers of Favorable Response to FcRn Inhibitors(INFORM)

RecruitingOBSERVATIONAL

Enrollment

50

Participants

Timeline

Start Date

July 9, 2024

Primary Completion Date

July 9, 2026

Study Completion Date

July 9, 2026

Conditions

Myasthenia Gravis Generalized

Trial Locations (1)

00168

RECRUITING

Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome

All Listed Sponsors

lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER